Skip to content
Tech News
← Back to articles

Molecular basis of polyadenylated RNA fate determination in the nucleus

read original get RNA Processing and Polyadenylation Kit → more articles
Why This Matters

This research uncovers the molecular mechanisms governing the fate of polyadenylated RNA within the nucleus, highlighting the roles of specific protein complexes such as UAP56, LENG8, and SAC3D1. Understanding these processes is crucial for advancing gene regulation knowledge and developing targeted therapies for diseases related to RNA processing errors, impacting both the biotech industry and clinical applications.

Key Takeaways

DNA sequences

All oligonucleotide plasmid vectors are annotated in Supplementary Table 6.

Purification of UAP56 and UAP56(Δ1–43)

His-tagged UAP56 constructs (10×His–3C–UAP56 or 10×His–3C–UAP56(Δ1–43), residues 44–428) were expressed in Escherichia coli BL21 DE3 RIL using autoinduction medium at 37 °C for 16 h. Following collection, cells were resuspended in lysis buffer (25 mM HEPES pH 7.9, 5% glycerol, 300 mM NaCl, 20 mM imidazole, 0.05% Tween-20, and protease inhibitors), disrupted via sonication, and clarified by centrifugation. The supernatant was sequentially filtered through 1-µm and 0.45-µm filters before affinity purification on a HisTrap HP 5 ml column (Cytiva), equilibrated in buffer A (25 mM HEPES pH 7.9, 5% glycerol, 300 mM NaCl, 20 mM imidazole). After washing with buffer A supplemented with 70 mM imidazole, bound proteins were eluted using a linear gradient of imidazole (70–200 mM in buffer A). Peak fractions were diluted in buffer B (25 mM HEPES pH 7.9, 5% glycerol, 1 mM DTT) to reduce the NaCl concentration to 100 mM and subsequently subjected to anion-exchange chromatography on a HiTrapQ 5 ml column (Cytiva), pre-equilibrated with buffer B. Elution was performed with a linear NaCl gradient (100–500 mM). Fractions containing UAP56 were concentrated and further purified via size-exclusion chromatography using a HiLoad 16/600 Superdex 200 pg column (Cytiva), equilibrated in buffer C (25 mM HEPES pH 7.9, 5% glycerol, 100 mM NaCl, 1 mM DTT). Peak fractions containing the purified protein were pooled, concentrated, flash-frozen, and stored at −80 °C.

Purification of LENG8–PSM and SAC3D1–PSM

Expression constructs encoding LENG8–PSM (10×His–MBP–LENG8491–800, 3×V5–PCID2, SEM1), SAC3D1–PSM (10×His–MBP–SAC3D148–404, 3×V5–PCID2, SEM1), SAC3D1–PCID2-UAP56–UCM–N-UBM–SEM1 (10×His–MBP–SAC3D148–404, 3×V5–PCID2–UAP56–UCM–N-UBM, SEM1), LENG8–PCID2–UAP56–N-UBM, SEM1 (10×His–MBP–LENG8491–800, 3×V5–PCID2–UAP56–N-UBM, SEM1) and their respective mutants were introduced into E. coli BL21 DE3 RIL (UCM is a UAP56-clamping motif). Cultures were grown in LB medium at 37 °C to OD600 ~1.0, at which point expression was induced with 0.5 mM IPTG, followed by overnight incubation at 18 °C. Cells were collected, lysed by sonication, and clarified by centrifugation. The supernatant was filtered (1 µm and 0.45 µm) and loaded onto a HisTrap HP 5 ml column equilibrated with buffer A, followed by washing and elution using a linear imidazole gradient up to 300 mM. Peak fractions were diluted to 50 mM NaCl in buffer B and subjected to anion-exchange purification on a HiTrapQ HP 5 ml column. After washing, complexes were eluted with a NaCl gradient (100–500 mM). Size-exclusion chromatography using a HiLoad 16/600 Superdex 200 pg column (Cytiva) in buffer C containing 250 mM NaCl yielded the final purified complex, which was concentrated, flash-frozen, and stored at −80 °C.

Recombinant EIF4A3 was purified as described previously16.

His-tagged DDX19 was expressed in E. coli BL21 DE3 RIL using LB medium, induced with 0.5 mM IPTG and expressed at 37 °C for 3 h. Following collection, cells were resuspended in lysis buffer (25 mM HEPES pH 7.9, 5% glycerol, 300 mM NaCl, 20 mM imidazole, and protease inhibitors), disrupted via sonication, and the lysate was cleared by centrifugation. The supernatant was sequentially filtered through 1-µm and 0.45-µm filters before affinity purification on a HisTrap HP 5 ml column (Cytiva), equilibrated in buffer A. The column was washed with buffer A containing 30 mM imidazole and bound proteins were eluted using a linear gradient of imidazole (50–300 mM). The peak fractions were incubated with 3C protease to cleave off the tag, and after 3C cleavage the peak fractions were diluted in buffer B to reduce the NaCl concentration to 50 mM, filtered through a 0.22-µm filter and next subjected to anion-exchange chromatography on a HiTrapQ 5 ml column (Cytiva), pre-equilibrated with buffer B supplemented with 50 mM NaCl. The column was washed with buffer B supplemented with 50 mM NaCl following sample loading. Elution was performed with a linear NaCl gradient (50–500 mM). Peak fractions containing DDX19 were concentrated and further purified via size-exclusion chromatography using a HiLoad 16/600 Superdex 200 pg column (Cytiva), equilibrated in buffer C. Peak fractions containing the purified protein were pooled, concentrated, flash-frozen, and stored at −80 °C.

Analytical gel filtration

For each purified protein or complex an aliquot of 62.5 μg was loaded onto a Superdex 200 Increase 5/150 column (Cytiva), equilibrated in the respective gel filtration buffers. Peak fractions were analysed via SDS–PAGE (4–12% gradient) and visualized by Coomassie staining.

... continue reading